# A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

> **NCT01692145** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.**

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** KCT-0809
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01692145
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692145, "A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01692145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*